Q3 2026 Earnings Call June 25, 2026 11:00 AM EDTCompany ParticipantsPeter Matt - CEO, President & DirectorPaul ...

David Craig’s operating manual for building biotech companies in today’s market is now available in hardcover and as an ...

Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome June 29, 2026 8:00 AM EDTCompany ParticipantsLina ...

It may only be June, but it has already been a busy NFL offseason. See where the Los Angeles Rams and others land in our NFL ...

Rapid development and rising demand of oligonucleotide drugs is fuelling revolutionary steps in biopharma investment and technology advancement for pipeline progression. The 2nd Oligonucleotides CMC & ...

Antibody-drug conjugates (ADCs) are transforming oncology with their ability to deliver potent cytotoxic agents directly to tumor cells, combining the targeting precision of monoclonal antibodies with ...

Aave founder Stani Kulechov pushed back against a report that Kraken parent firm Payward is in talks to buy a 15% stake in ...

SpaceX (SPCX) shed about $400 billion in a day after its record IPO. Is it a good time to buy SPCX — and do crypto-rail ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

With hardware prices spiraling, AI vendors ramping up token costs, and models becoming drastically slimmer and more economical, running AI models locally isn’t just going to be a good idea whose time ...